An assessment of randomized controlled trials (RCTs) for non-communicable diseases (NCDs): More and higher quality research is required in less developed countries

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Fan, Hong ^a   Song, Fujian ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLASSIFICATION; DEVELOPING COUNTRY; HUMAN; MEDICAL RESEARCH; NEEDS ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT;

BIOMEDICAL RESEARCH; CHRONIC DISEASE; DEVELOPING COUNTRIES; HUMANS; NEEDS ASSESSMENT; QUALITY IMPROVEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84939457014     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13221     Document Type: Article

References (104)

1. Di-Cesare, M. et al. Inequalities in non-communicable diseases and effective responses. Lancet 381, 585-597, doi: 10.1016/ s0140-6736(12)61851-0 (2013).
2. Cerqueira, M. T. et al. Global response to non-communicable disease. BMJ 342, d3823, doi: 10.1136/bmj.d3823 (2011).
3. WHO. Global status report on noncommunicable diseases 2014. (2014) Available at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854-eng.pdf?ua=1. (Accessed: 24th June 2015).
4. Cao, X. A call for global research on non-communicable diseases. Lancet 385, e5-6, doi: 10.1016/s0140-6736(14)62383-7 (2015).
5. Wise, J. Research network aims to tackle chronic disease in developing world. BMJ 338, b2440, doi: 10.1136/bmj.b2440 (2009).
6. Smith, R. A global research network for non-communicable diseases. Lancet 383, 1446-1447, doi: 10.1016/s0140-6736(13)61808- 5 (2014).
7. Mendis, S., Yach, D., Bengoa, R., Narvaez, D. & Zhang, X. Research gap in cardiovascular disease in developing countries. Lancet. 361, 2246-2247, doi: 10.1016/s0140-6736(03)13753-1 (2003).
8. Rottingen, J. A. et al. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? Lancet 382, 1286-1307, doi: 10.1016/s0140-6736(13)61046-6 (2013).
9. Heneghan, C. et al. Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ open 3, doi: 10.1136/bmjopen-2013-003298 (2013).
10. Miranda, J. J. & Zaman, M. J. Exporting 'failure': why research from rich countries may not benefit the developing world. Rev Saude Publica. 44, 185-189 (2010).
11. Chinnock, P., Siegfried, N. & Clarke, M. Is evidence-based medicine relevant to the developing world? PLoS Med. 2, e107, doi: 10.1371/journal.pmed.0020107 (2005).
12. Panagiotou, O. A., Contopoulos-Ioannidis, D. G. & Ioannidis, J. P. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. BMJ 346, f707, doi: 10.1136/bmj.f707 (2013).
13. Higgins, J. T., Green, S. S. Cochrane Handbook for Systematic Reviews of Interventions (The Cochrane Collaboration & Wiley- Blackwell, 2008).
14. THE WORLD BANK. Country and Lending Groups. (2014) Available at: http://data.worldbank.org/about/country-andlending-groups (Accessed: 9th March 2015).
15. STATA. Multilevel mixed-effects reference manual release 13. (StataCorp LP, Texas, 2013).
16. Amin, F., AI-Hajeri, A., Civelek, B., Fedorowicz, Z. & Manzer, B. M. Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2, CD007219, doi: 10.1002/14651858.CD007219.pub2 (2010).
17. Arguedas, J. A., Leiva, V. & Wright, J. M. Blood pressure targets for hypertension in people with diabetes mellitus. Cochrane Database Syst Rev. 10, CD008277, doi: 10.1002/14651858.CD008277.pub2 (2013).
18. Arsenault, K. A. et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 1, CD003611, doi: 10.1002/14651858.CD003611.pub3 (2013).
19. Baharoglu, M. I. et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 8, CD001245, doi: 10.1002/14651858.CD001245.pub2 (2013).
20. Bath, P. M., Sprigg, N. & England, T. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev. 6, CD005207, doi: 10.1002/14651858.CD005207.pub4 (2013).
21. Batterink, J., Stabler, S. N., Tejani, A. M. & Fowkes, C. T. Spironolactone for hypertension. Cochrane Database Syst Rev. 8, CD008169, doi: 10.1002/14651858.CD008169.pub2 (2010).
22. Baumeister, H., Hutter, N. & Bengel, J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 9, CD008012, doi: 10.1002/14651858.CD008012.pub3 (2011).
23. Brady, M. C., Kelly, H., Godwin, J. & Enderby, P. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev. 5, CD000425, doi: 10.1002/14651858.CD000425.pub3 (2012).
24. Bruins-Slot, K. M. & Berge, E. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev. 8, CD008980, doi: 10.1002/14651858.CD008980.pub2 (2013).
25. Buchleitner, A. M., Martínez-Alonso, M., Hernández, M., Solà, I. & Mauricio, D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 9, CD007315, doi: 10.1002/14651858.CD007315.pub2 (2012).
26. Campbell-Burton, C. A. et al. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 12, CD008860, doi: 10.1002/14651858.CD008860.pub2 (2011).
27. Ciccone, A., Celani, M. G., Chiaramonte, R., Rossi, C. & Righetti, E. Continuous versus intermittent physiological monitoring for acute stroke. Cochrane Database Syst Rev. 5, CD008444, doi: 10.1002/14651858.CD008444.pub2 (2013).
28. Clarkesmith, D. E., Pattison, H. M. & Lane, D. A. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev. 6, CD008600, doi: 10.1002/14651858.CD008600.pub2 (2013).
29. Clifford, D. M. et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2, CD006536, doi: 10.1002/14651858.CD006536.pub3 (2012).
30. Coupar, F., Pollock, A., Legg, L. A., Sackley, C. & Van-Vliet, P. Home-based therapy programmes for upper limb functional recovery following stroke. Cochrane Database Syst Rev. 5, CD006755, doi: 10.1002/14651858.CD006755.pub2 (2012).
31. De-Lima, L. G., Soares, B. G. O., Saconato, H., Atallah, A. N. & Da- Silva, E.M. Beta-blockers for preventing stroke recurrence. Cochrane Database Syst Rev. 10, CD007890, doi: 10.1002/14651858.CD007890.pub3 (2013).
32. Demetrios, M., Khan, F., Turner-Stokes, L., Brand, C. & Mc-Sweeney, S. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev. 6, CD009689, doi: 10.1002/14651858.CD009689.pub2 (2013).
33. Diao, D., Wright, J. M., Cundiff, D. K. & Gueyffier, F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev. 8, CD006742, doi: 10.1002/14651858.CD006742.pub2 (2012).
34. Elsner, B., Kugler, J., Pohl, M. & Mehrholz, J. Transcranial direct current stimulation (tDCS) for improving function and activities of daily living in patients after stroke. Cochrane Database Syst Rev. 11, CD009645, doi: 10.1002/14651858.CD009645. pub2 (2013).
35. Fearon, P. & Langhorne, P. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev. 9, CD000443, doi: 10.1002/14651858.CD000443.pub3 (2012).
36. Fisher, S. A. et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev. 4, CD007888, doi: 10.1002/14651858.CD007888.pub2 (2014).
37. Fletcher-Smith, J. C., Walker, M. F., Cobley, C. S., Steultjens, E. M. & Sackley, C. M. Occupational therapy for care home residents with stroke. Cochrane Database Syst Rev. 6, CD010116, doi: 10.1002/14651858.CD010116.pub2 (2013).
38. Forster, A. et al. Information provision for stroke patients and their caregivers. Cochrane Database Syst Rev. 11, CD001919, doi: 10.1002/14651858.CD001919.pub3 (2012).
39. Geeganage, C., Beavan, J., Ellender, S. & Bath, P. M. W. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 10, CD000323, doi: 10.1002/14651858.CD000323.pub2 (2012).
40. George, S., Crotty, M., Gelinas, I. & Devos, H. Rehabilitation for improving automobile driving after stroke. Cochrane Database Syst Rev. 2, CD008357, doi: 10.1002/14651858.CD008357.pub2 (2014).
41. Gois, P. H. F. & Souza, E. R. M. Pharmacotherapy for hyperuricemia in hypertensive patients. Cochrane Database Syst Rev. 1, CD008652, doi: 10.1002/14651858.CD008652.pub2. Review (2013).
42. Guo, J., Shi, Z., Yang, K., Tian, J. H. & Jiang, L. Endothelin receptor antagonists for subarachnoid hemorrhage. Cochrane Database Syst Rev. 9, CD008354, doi: 10.1002/14651858.CD008354.pub2 (2012).
43. Hao, Z. et al. Fibrinogen depleting agents for acute ischaemic stroke. Cochrane Database Syst Rev. 3, CD000091, doi: 10.1002/14651858.CD000091.pub2 (2012).
44. Hao, Z., Wang, D., Zeng, Y. & Liu, M. Repetitive transcranial magnetic stimulation for improving function after stroke. Cochrane Database Syst Rev. 5, CD008862, doi: 10.1002/14651858.CD008862.pub2 (2013).
45. Hemmingsen, B. et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 11, CD008143, doi: 10.1002/14651858.CD008143.pub3 (2013).
46. Hemmingsen, B. et al. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus. Cochrane Database Syst Rev. 4, CD009008, doi: 10.1002/14651858.CD009008.pub2 (2013).
47. Heran, B. S. et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 7, CD001800, doi: 10.1002/14651858.CD001800.pub2 (2011).
48. Heran, B. S., Chen, J. M., Wang, J. J. & Wright, J. M. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension. Cochrane Database Syst Rev. 11, CD008167, doi: 10.1002/14651858. CD008167.pub3 (2012).
49. Heran, B. S., Galm, B. P. & Wright, J. M. Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev. 8, CD004643, doi: 10.1002/14651858.CD004643.pub3 (2012).
50. Horjus, D. L., Oudman, I., Van-Montfrans, G. A. & Brewster, L. M. Creatine and creatine analogues in hypertension and cardiovascular disease. Cochrane Database Syst Rev. 11, CD005184, doi: 10.1002/14651858.CD005184.pub2. (2011).
51. Laver, K. E., George, S., Thomas, S., Deutsch, J. E. & Crotty, M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2, CD008349, doi: 10.1002/14651858.CD008349.pub3. (2011).
52. Leach, M. J. & Kumar, S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 9, CD007170, doi: 10.1002/14651858. CD007170.pub2 (2012).
53. Liakopoulos, O. J., Kuhn, E. W., Slottosch, I., Wassmer, G. & Wahlers, T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev. 4, CD008493, doi: 10.1002/14651858.CD008493.pub2 (2012).
54. Lin, S. et al. External counterpulsation for acute ischaemic stroke. Cochrane Database Syst Rev. 1, CD009264, doi: 10.1002/14651858.CD009264.pub2 (2012).
55. Lip, G. Y. H., Felmeden, D. C. & Dwivedi, G. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev. 12, CD003186. doi: 10.1002/14651858.CD003186.pub3 (2011).
56. Liu, J. & Wang, L. N. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev. 2, CD009622, doi: 10.1002/14651858.CD009622.pub2 (2013).
57. Liu, Z., Liu, L., Zhang, Z., Chen, Z. & Zhao, B. Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 4, CD008184, doi: 10.1002/14651858.CD008184.pub2 (2013).
58. Liu, J. & Wang, L. N. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Cochrane Database Syst Rev. 1, CD010693, doi: 10.1002/14651858.CD010693.pub2 (2014).
59. Liu, C., Chen, J., Gao, Y., Deng, B. & Liu, K. Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Syst Rev. 2, CD004434, doi: 10.1002/14651858.CD004434.pub5 (2013).
60. Loetscher, T. & Lincoln, N. B. Cognitive rehabilitation for attention deficits following stroke. Cochrane Database Syst Rev. 5, CD002842, doi: 10.1002/14651858.CD002842.pub2 (2013).
61. Lyrer, P. & Engelter, S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 10, CD000255, doi: 10.1002/14651858.CD000255.pub2 (2010).
62. MacKay-Lyons, M., Thornton, M., Ruggles, T. & Che, M. Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack. Cochrane Database Syst Rev. 3, CD008656, doi: 10.1002/14651858.CD008656. pub2 (2013).
63. Malanda, U. L. et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 1, CD005060, doi: 10.1002/14651858.CD005060.pub3 (2012).
64. Mead, G. E. et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 11, CD009286, doi: 10.1002/14651858.CD009286.pub2 (2012).
65. Musini, V. M., Rezapour, P., Wright, J. M., Bassett, K. & Jauca, C. D. Blood pressure lowering efficacy of loop diuretics for primary hypertension. Cochrane Database Syst Rev. 8, CD003825, doi: 10.1002/14651858.CD003825.pub3 (2012).
66. Onady, G. M. & Stolfi, A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev. 7, CD004730, doi: 10.1002/14651858.CD004730.pub3 (2013).
67. Ooi, C. P. & Loke, S. C. Colesevelam for type 2 diabetes mellitus. Cochrane Database Syst Rev. 12, CD009361, doi: 10.1002/14651858.CD009361.pub2 (2012).
68. Ooi, C. P. & Loke, S. C. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst Rev. 9, CD009128, doi: 10.1002/14651858. CD009128.pub3 (2013).
69. O'Rourke, K., Berge, E., Walsh, C. D. & Kelly, P. J. Percutaneous vascular interventions for acute ischaemic stroke. Cochrane Database Syst Rev. 10, CD007574, doi: 10.1002/14651858.CD007574.pub2 (2010).
70. Pal, K. et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 3, CD008776, doi: 10.1002/14651858.CD008776.pub2 (2013).
71. Rees, K. et al. Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials. Cochrane Database Syst Rev. 11, CD008535, doi: 10.1002/14651858.CD008535.pub2 (2011).
72. Salazar, C. A., del-Aguila, D. & Cordova, E. G. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. Cochrane Database Syst Rev. 3, CD009893, doi: 10.1002/14651858.CD009893.pub2 (2014).
73. Sandercock, P. A. & Soane, T. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev. 9, CD000064, doi: 10.1002/14651858.CD000064.pub2 (2011).
74. Saunders, D. H., Sanderson, M., Brazzelli, M., Greig, C. A. & Mead, G. E. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 10, CD003316, doi: 10.1002/14651858.CD003316.pub5 (2013).
75. Shyangdan, D. S. et al. Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database Syst Rev. 10, CD006423, doi: 10.1002/14651858.CD006423.pub2 (2011).
76. Siebenhofer, A. et al. Long-term effects of weight-reducing diets in hypertensive patients. Cochrane Database Syst Rev. 9, CD008274, doi: 10.1002/14651858. CD008274.pub2 (2011).
77. Siebenhofer, A. et al. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev. 3, CD007654, doi: 10.1002/14651858.CD007654.pub3 (2013).
78. Sridharan, K., Mohan, R., Ramaratnam, S. & Panneerselvam, D. Ayurvedic treatments for diabetes mellitus. Cochrane Database Syst Rev. 12, CD008288, doi: 10.1002/14651858.CD008288.pub2 (2011).
79. Stabler, S. N., Tejani, A. M., Huynh, F. & Fowkes, C. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. Cochrane Database Syst Rev. 8, CD007653, doi: 10.1002/14651858.CD007653.pub2 (2012).
80. Svircevic, V. et al. Epidural analgesia for cardiac surgery. Cochrane Database Syst Rev. 6, CD006715, doi: 10.1002/14651858. CD006715.pub2 (2013).
81. Swinnen, S. G., Simon, A. C., Holleman, F., Hoekstra, J. B. & DeVries, J. H. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database Syst Rev. 7, CD006383, doi: 10.1002/14651858.CD006383.pub2 (2011).
82. Stroke Unit Trialists' Collaboration1. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 9, CD000197, doi: 10.1002/14651858.CD000197.pub3 (2013).
83. Sykes, L., Wood, E. & Kwan, J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 1, CD005398, doi: 10.1002/14651858.CD005398.pub3 (2014).
84. Usinger, L., Reimer, C. & Ibsen, H. Fermented milk for hypertension. Cochrane Database Syst Rev. 4, CD008118, doi: 10.1002/14651858.CD008118.pub2 (2012).
85. Vale, N. et al. Statins for acute coronary syndrome. Cochrane Database Syst Rev. 9, CD006870, doi: 10.1002/14651858.CD006870. pub3 (2011).
86. Valentine, N., Van de laar, F. A. & Van-Driel, M. L. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database Syst Rev. 11, CD005449, doi: 10.1002/14651858.CD005449. pub2 (2012).
87. Verheyden, G. S. et al. Interventions for preventing falls in people after stroke. Cochrane Database Syst Rev. 5, CD008728, doi: 10.1002/14651858.CD008728.pub2 (2013).
88. Wei, I., Pappas, Y., Car, J., Sheikh, A. & Majeed, A. Computer-assisted versus oral-and-written dietary history taking for diabetes mellitus. Cochrane Database Syst Rev. 12, CD008488, doi: 10.1002/14651858.CD008488.pub2 (2011).
89. Westendorp, W. F. et al. Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev. 1, CD008530, doi: 10.1002/14651858.CD008530.pub2 (2012).
90. Wiysonge, C. S. et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 11, CD002003, doi: 10.1002/14651858. CD002003.pub4 (2012).
91. Wong, G. W. & Wright, J. M. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension. Cochrane Database Syst Rev. 2, CD007452, doi: 10.1002/14651858.CD007452.pub2 (2014).
92. Xiao, Y., Luo, M., Wang, J. & Luo, H. Inspiratory muscle training for the recovery of function after stroke. Cochrane Database Syst Rev. 5, CD009360, doi: 10.1002/14651858.CD009360.pub2 (2012).
93. Zhao, P., Xu, P., Wan, C. & Wang, Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 10, CD004184, doi: 10.1002/14651858.CD004184.pub2 (2011).
94. Zheng, G. H., Liu, J. P., Chu, J. F., Mei, L. & Chen, H. Y. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease. Cochrane Database Syst Rev. 5, CD009581, doi: 10.1002/14651858.CD009581.pub2 (2013).
95. Zhou, Q. et al. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev. 4, CD005052, doi: 10.1002/14651858.CD005052.pub5 (2014).
96. Zhu, F., Lee, A. & Chee, Y. E. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 10, CD003587, doi: 10.1002/14651858.CD003587.pub2 (2012).
97. Ziganshina, L. E., Abakumova, T. & Kuchaeva, A. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 4, CD007026, doi: 10.1002/14651858.CD007026.pub2 (2010).
98. Zhang, D., Freemantle, N. & Cheng, K. K. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol. 64, 90-95, doi: 10.1016/j.jclinepi.2010.02.010 (2011).
99. Morrison, A. et al. The effect of english-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 28, 138-144, doi: 10.1017/s0266462312000086 (2012).
100. Ioannidis, J. P. et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383, 166-175, doi: 10.1016/s0140-6736(13)62227-8 (2014).
101. Chan, A. W. et al. Increasing value and reducing waste: addressing inaccessible research. Lancet. 383, 257-266, doi: 10.1016/ s0140-6736(13)62296-5 (2014).
102. Jones, A. C. & Geneau, R. Assessing research activity on priority interventions for non-communicable disease prevention in low- and middle-income countries: a bibliometric analysis. Glob Health Action 5, 1-13, doi: 10.3402/gha.v5i0.18847 (2012).
103. Lawrence, J., Bai, S., Hung, H. M. & O'Neill, R. Regional treatment effects in studies of cardiorenal drugs: a summary of recent clinical trials. J Am Coll Cardiol. 60, 1117-1118, doi: 10.1016/j.jacc.2012.04.051 (2012).
104. Lu, Z. et al. Effectiveness of interventions for hypertension care in the community-a meta-analysis of controlled studies in China. BMC Health Serv Res. 12, 216, doi: 10.1186/1472-6963-12-216 (2012).